Dr Reddy’s Labs Announces Commercial Launch Of Covid19 Drug 2-DG, MRP Of Each Sachet Fixed At ₹990
DRDO Developed '2-DG' Drug Inhibits Coronavirus Multiplication, Likely To Work Against All COVID Variants: Study
DRDO To Transfer Technology Of Anti-COVID Drug '2-DG' To India Pharma Firms, Invites EoI
First Batch Of DRDO’s Anti-Covid “2-DG” Drug To Be Released By Defence Minister Rajnath Singh Today
